A marked reduction in PP2A activity was also found in CD34+ stem cells isolated from bone marrow and peripheral blood of JAK2-driven myeloproliferative neoplasms (MPN), compared with those isolated from healthy individuals [56]. This evidence concerns the gene PTPA and myeloproliferative disorder.